Feb 19, 2021

Volume 16 Number 14

In this edition: management of Infective endocarditis after TAVI; characterisation of embolic debris with different TAVI devices; IVUS assessment to predict or prevent coronary artery occlusion after valve-in-valve TAVI. A mini focus on antithrombotic therapy in coronary interventions: the PENDULUM registry and high bleeding risk; clopidogrel vs ticagrelor in STEMI patients from the MIRTOS study; the TALOS-AMI trial design for DAPT de-escalation. An EAPCI position statement on elective cardiovascular procedures during the COVID-19 pandemic; the DESSOLVE III OCT study; the prognostic value of thermodilution-derived coronary flow capacity in patients with stable CAD; ventricular tachycardia, revascularisation of infarct-related artery chronic occlusion and myocardial scar; and more...

Interventions for valvular disease and heart failure

A review of recommendations for infective endocarditis prevention in patients undergoing transcatheter aortic valve implantation
Conen A, Stortecky S, Moreillon P, Hannan M, Franzeck F, Jeger RV, Widmer A
Heterogeneity of debris captured by cerebral embolic protection filters during TAVI
Kroon H, von der Thusen J, Ziviello F, van Wiechen M, Ooms J, Kardys I, Schipper M, van Gils L, Daemen J, de Jaegere P, Van Mieghem NM

Editorial comment

Cerebral embolic protection during TAVI: the game is not over
Bagur R, Sposato L
Intravascular ultrasound assessment of coronary ostia following valve-in-valve transcatheter aortic valve implantation
Pighi M, Lunardi M, Pesarini G, Castriota F, Venturi G, Gottin L, Scarsini R, Ferrero V, Ribichini F
Intravascular ultrasound guidance for valve-in-valve transcatheter pulmonary valve replacement
Kalinczuk L, Swierczewski M, Mintz GS, Demkow M

Coronary interventions - Mini Focus on Antithrombotic Therapy

High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registry
Nakamura M, Kadota K, Nakao K, Nakagawa Y, Shite J, Yokoi H, Kozuma K, Tanabe K, Iijima R, Harada A, Kuroda T, Murakami Y

Editorial comment

Consolidating the value of the standardised ARC-HBR definition
Gargiulo G, Esposito G
Ticagrelor versus clopidogrel in patients with STEMI treated with thrombolysis: the MIRTOS trial
Hamilos M, Kanakakis J, Anastasiou I, Karvounis C, Vasilikos V, Goudevenos J, Michalis L, Koutouzis M, Tsiafoutis I, Raisakis K, Stakos D, Hahalis G, Vardas P

Editorial comment

Coronary interventions

Performing elective cardiac invasive procedures during the COVID-19 outbreak: a position statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Chieffo A, Tarantini G, Naber CK, Barbato E, Roffi M, Stefanini G, Buchanan G, Buszman P, Moreno R, Zawiślak B, Cayla G, Danenberg H, Da Silveira J, Nef H, James S, Mauri Ferre J, Voskuil M, Witt N, Windecker S, Baumbach A, Dudek D
Neointimal hyperplasia of ultra-thin stents with microcrystalline sirolimus or durable polymer everolimus-eluting stents: 6- and 24-month results of the DESSOLVE III OCT study
Milewski K, Takahashi K, Asano T, Katagiri Y, Hochul M, Buszman P, Tomaniak M, Gorycki B, Zurakowski A, Janas A, Mlodziankowski A, Kachel M, Wykrzykowska JJ, Wijns W, de Winter R, Buszman P, Onuma Y, Serruys PW
Prognostic significance of thermodilution-derived coronary flow capacity in patients with deferred revascularisation
Hoshino M, Kanaji Y, Hamaya R, Kanno Y, Hada M, Yamaguchi M, Sumino Y, Usui E, Murai T, Lee T, Yonetsu T, Kakuta T

Editorial comment

Receive our newsletter

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved